Asset Details
Do you wish to reserve the book?
Pharmacokinetic Evaluation and Exploration of Antifungal Activity of Synthesized Pyrazole-Based Compounds
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pharmacokinetic Evaluation and Exploration of Antifungal Activity of Synthesized Pyrazole-Based Compounds
Do you wish to request the book?
Pharmacokinetic Evaluation and Exploration of Antifungal Activity of Synthesized Pyrazole-Based Compounds
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pharmacokinetic Evaluation and Exploration of Antifungal Activity of Synthesized Pyrazole-Based Compounds
2026
Overview
The synthesized pyrazole-based compounds were evaluated for their pharmacokinetic properties and antifungal activity. The pharmacokinetic results, obtained through the pKCSM server, showed favorable solubility, human intestinal absorption (HIA) greater than 70%, and good permeability to the central nervous system (CNS) for certain compounds, with low inhibition of CYP450 enzymes and predicted toxicity within safe limits. Regarding antifungal activity, the compounds demonstrated effective inhibition of the growth of two pathogenic fungi, with minimum inhibitory concentrations (MIC) ranging from 2 to 16 µg/mL. These results suggest that these compounds possess an optimal pharmacokinetic profile and promising antifungal activity, making them attractive candidates for clinical development. Thus, this study identifies compounds with high therapeutic potential for the treatment of fungal infections while ensuring a good safety profile for future development.
Publisher
EDP Sciences
